Literature DB >> 21858836

Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.

Roger F Uren1, Robert Howman-Giles, David Chung, John F Thompson.   

Abstract

Melanoma has a high potential to develop metastases. Accurate staging is essential for appropriate management. Sentinel node (SN) status is a powerful prognostic factor in early stage melanoma. Staging is assisted by SN biopsy after lymphoscintigraphy to locate all true SNs prior to biopsy. PET using F18-FDG can detect metastases and is used to restage patients with AJCC Stages III and IV disease before planning surgery with curative intent.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21858836     DOI： 10.1002/jso.21770

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  6 in total

1.  The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Authors:  Lutz Kretschmer; Hans Peter Bertsch; Pawel Bardzik; Johannes Meller; Simin Hellriegel; Kai-Martin Thoms; Michael Peter Schön; Carsten Oliver Sahlmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-15       Impact factor: 9.236

2.  Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.

Authors:  Maria Danielsen; Andreas Kjaer; Max Wu; Lea Martineau; Mehdi Nosrati; Stanley Pl Leong; Richard W Sagebiel; James R Miller; Mohammed Kashani-Sabet
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

3.  External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.

Authors:  N A Ipenburg; O E Nieweg; T Ahmed; R van Doorn; R A Scolyer; G V Long; J F Thompson; S Lo
Journal:  Br J Surg       Date:  2019-07-16       Impact factor: 6.939

4.  Successful treatment of triple primary tumor.

Authors:  Sidika Kurul; Zuleyha Akgun; Esra Kaytan Saglam; Mert Basaran; Serap Yucel; Sitki Tuzlali
Journal:  Int J Surg Case Rep       Date:  2013-08-27

5.  Current management of patients with melanoma who are found to be sentinel node-positive.

Authors:  Amanda A G Nijhuis; Andrew J Spillane; Jonathan R Stretch; Robyn P M Saw; Alexander M Menzies; Roger F Uren; John F Thompson; Omgo E Nieweg
Journal:  ANZ J Surg       Date:  2019-10-30       Impact factor: 1.872

6.  Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo 18F-FDG-PET.

Authors:  Johannes Schwenck; Barbara Schörg; Francesco Fiz; Dominik Sonanini; Andrea Forschner; Thomas Eigentler; Benjamin Weide; Manuela Martella; Irene Gonzalez-Menendez; Cristina Campi; Gianmario Sambuceti; Ferdinand Seith; Leticia Quintanilla-Martinez; Claus Garbe; Christina Pfannenberg; Martin Röcken; Christian la Fougere; Bernd J Pichler; Manfred Kneilling
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.